Page last updated: 2024-08-24

ibandronic acid and prednisolone

ibandronic acid has been researched along with prednisolone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Rexer, H1
Cellarius, C; Claassen, H; Glüer, CC; Kurz, B; Scholz-Ahrens, KE; Schrezenmeir, J; Schünke, M1
Griffith, JF; Hung, VY; Kwok, AW; Lee, KK; Lee, VW; Leung, PC; Li, EK; Li, M; Qin, L; Tam, LS; Wong, KC; Zhu, TY1
Eufémia Calmeiro, M; Gil, F; Gil, J; Mariano, P; Silva, S1

Reviews

1 review(s) available for ibandronic acid and prednisolone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for ibandronic acid and prednisolone

ArticleYear
Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.
    Arthritis research & therapy, 2010, Volume: 12, Issue:5

    Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Glucocorticoids; Humans; Hydroxycholecalciferols; Ibandronic Acid; Lupus Erythematosus, Systemic; Middle Aged; Osteoporosis; Prednisolone; Tomography Scanners, X-Ray Computed

2010

Other Studies

4 other study(ies) available for ibandronic acid and prednisolone

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
[Therapy of painful bone metastases in patients with prostate carcinoma. The AP 32/02 Study of the AUO].
    Der Urologe. Ausg. A, 2004, Volume: 43, Issue:9

    Topics: Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Male; Mitoxantrone; Pain; Patient Selection; Prednisolone; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome

2004
Extracellular matrix changes in knee joint cartilage following bone-active drug treatment.
    Cell and tissue research, 2006, Volume: 324, Issue:2

    Topics: Alkaline Phosphatase; Animals; Bone Density Conservation Agents; Calcium; Cartilage, Articular; Chondrocytes; Diphosphonates; Estrogens; Extracellular Matrix; Female; Glycosaminoglycans; Ibandronic Acid; Ovariectomy; Prednisolone; Sodium Fluoride; Swine; Swine, Miniature; Vitamin D Deficiency

2006
SAPHO syndrome: the value of classic drugs in the era of biologics.
    Dermatology online journal, 2020, May-15, Volume: 26, Issue:5

    Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Bone and Bones; Bone Density Conservation Agents; Cyclosporine; Drug Therapy, Combination; Female; Humans; Ibandronic Acid; Immunosuppressive Agents; Middle Aged; Prednisolone; Radionuclide Imaging

2020